#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4421021	F	Reduction in food intake in Sprague-Dawley rat at 3 nmol/kg measured 0 to 24 hrs post dose relative to control	Rattus norvegicus	45	ALA4420076	organism-based format	Patent Bioactivity Data
2.	ALA4421022	F	Reduction in food intake in Sprague-Dawley rat at 3 nmol/kg measured 24 to 48 hrs post dose relative to control	Rattus norvegicus	45	ALA4420076	organism-based format	Patent Bioactivity Data
3.	ALA4421023	F	Agonist activity at human amylin receptor expressed in BHK570 cells co-expressing RAMP3 assessed as increase in intracellular cAMP concentration incubated for 3 hrs in absence of albumin by CRE luciferase reporter gene assay	Homo sapiens	143	ALA4420076	cell-based format	Patent Bioactivity Data
4.	ALA4421024	F	Agonist activity at human calcitonin receptor expressed in BHK570 cells assessed as increase in intracellular cAMP concentration incubated for 3 hrs in absence of albumin by CRE luciferase reporter gene assay	Homo sapiens	143	ALA4420076	cell-based format	Patent Bioactivity Data
5.	ALA4421025	F	Agonist activity at human amylin receptor expressed in BHK570 cells co-expressing RAMP3 assessed as increase in intracellular cAMP concentration incubated for 3 hrs in presence of 10% FBS by CRE luciferase reporter gene assay	Homo sapiens	96	ALA4420076	cell-based format	Patent Bioactivity Data
6.	ALA4421026	F	Agonist activity at human calcitonin receptor expressed in BHK570 cells assessed as increase in intracellular cAMP concentration incubated for 3 hrs in presence of 10% FBS by CRE luciferase reporter gene assay	Homo sapiens	96	ALA4420076	cell-based format	Patent Bioactivity Data
7.	ALA4421029	P	Solubility in 100 mM glycylglycine buffer at pH 3.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
8.	ALA4421030	P	Solubility in 100 mM glycylglycine buffer at pH 4.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
9.	ALA4421031	P	Solubility in 100 mM bistrispropane buffer at pH 6.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
10.	ALA4421032	P	Solubility in 100 mM glycylglycine buffer at pH 5.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
11.	ALA4421033	P	Solubility in 100 mM bistrispropane buffer at pH 6.5 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
12.	ALA4421034	P	Solubility in 100 mM bistrispropane buffer at pH 7.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
13.	ALA4421035	P	Solubility in 100 mM bistrispropane buffer at pH 7.5 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
14.	ALA4421036	P	Solubility in 100 mM bistrispropane buffer at pH 8.0 incubated for 18 hrs by UPLC analysis		130	ALA4420076	small-molecule physicochemical format	Patent Bioactivity Data
15.	ALA4421072	B	Displacement of [125I]-labeled rat amylin from human amylin receptor expressed in BHK tkts13 whole cells co-expressing RAMP3 incubated for 60 mins by scintillation proximity assay	Homo sapiens	91	ALA4420076	cell-based format	Patent Bioactivity Data
16.	ALA4421073	B	Displacement of [125I]-labeled human calcitonin from human calcitonin receptor expressed in BHK tkts13 whole cells incubated for 60 mins by scintillation proximity assay	Homo sapiens	91	ALA4420076	cell-based format	Patent Bioactivity Data